Product NDC: | 10956-020 |
Proprietary Name: | Premier Value Chest Congestion and cough releif |
Non Proprietary Name: | Dextromethorphan Hydrobromide / Guaifenesin |
Active Ingredient(s): | 20; 400 mg/1; mg/1 & nbsp; Dextromethorphan Hydrobromide / Guaifenesin |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10956-020 |
Labeler Name: | Reese Pharmaceutical Co |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20091130 |
Package NDC: | 10956-020-01 |
Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (10956-020-01) > 50 TABLET in 1 BOTTLE, PLASTIC (10956-020-11) |
NDC Code | 10956-020-01 |
Proprietary Name | Premier Value Chest Congestion and cough releif |
Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (10956-020-01) > 50 TABLET in 1 BOTTLE, PLASTIC (10956-020-11) |
Product NDC | 10956-020 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Dextromethorphan Hydrobromide / Guaifenesin |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20091130 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Reese Pharmaceutical Co |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
Strength Number | 20; 400 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |